Han hablado de GILEAD pero no de DVAX, es cierto.....lo que si hablan es de una reduccion del 98% que parece es bastante bueno.
La cosa es que han estado apunto de tocar los 10$....hace menos de un año cuando la pille yo tenia un PO de 16$ creo recordar basandose en esta fase II
"Arrowhead said in human studies of patients who tested positive for the E-antigen, HBeAg, a single dose of ARC-520 reduced the antigen by up to 98%. The E-antigen is a protein made by the virus, which indicates that there is a lot of virus in the blood and it can be easily spread to others.
Hepatitis B can lead to liver diseases such as cirrhosis and cancer.
The treatment also reduced the S-antigen by up to 99% in human patients. The S-antigen is a surface antigen found in the blood of someone infected with hepatitis B. Arrowhead said it is currently conducting phase-two human trials of the drug.
The chimpanzee studies, which gave up to 11 monthly doses to 9 chimps, reduced the S-antigen by amounts ranging from 81% to 99%.
Arrowhead said it hasn't seen any serious or severe side effects in humans or chimps."